4//SEC Filing
Sanders Dale 4
Accession 0001562180-20-005870
CIK 0001636422other
Filed
Sep 2, 8:00 PM ET
Accepted
Sep 3, 7:01 PM ET
Size
11.2 KB
Accession
0001562180-20-005870
Insider Transaction Report
Form 4
Sanders Dale
Chief Operating Officer
Transactions
- Exercise/Conversion
Stock Option (Right to Buy)
2020-09-01−27,500→ 443,389 totalExercise: $10.80Exp: 2028-09-27→ Common Stock (27,500 underlying) - Sale
Common Stock
2020-09-01$32.06/sh−13,410$429,925→ 164,484 total - Sale
Common Stock
2020-09-01$31.29/sh−14,090$440,876→ 177,894 total - Exercise/Conversion
Common Stock
2020-09-01$10.80/sh+27,500$297,000→ 191,984 total
Footnotes (4)
- [F1]The sales reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person on November 26, 2019, in accordance with Rule 10b5-1.
- [F2]Represents a weighted average price. These shares were sold by the Reporting Person in multiple transactions at prices ranging from $30.86 to $31.85, inclusive.
- [F3]Represents a weighted average price. These shares were sold by the Reporting Person in multiple transactions at prices ranging from $31.89 to $32.35, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in Footnotes (2) and (3).
- [F4]25% of the 472,223 shares underlying the options vested in an annual installment on September 25, 2019 and the remaining balance vested or will vest in equal monthly installments until the option vests in full on September 25, 2022.
Documents
Issuer
Health Catalyst, Inc.
CIK 0001636422
Entity typeother
Related Parties
1- filerCIK 0001780970
Filing Metadata
- Form type
- 4
- Filed
- Sep 2, 8:00 PM ET
- Accepted
- Sep 3, 7:01 PM ET
- Size
- 11.2 KB